Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra™ and ProQuad™ live attenuated combined vaccines

Vaccine

Volumn 27, Issue 16, 2009, Pages 2265-2273

  Tillieux, Sueli L ^a   Halsey, Wendy S ^b   Sathe, Ganesh M ^b   Vassilev, Ventzislav ^a  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Complete sequence; Measles mumps rubella; Vaccine

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PRIORIX TETRA; UNCLASSIFIED DRUG;

ARTICLE; IMMUNE RESPONSE; MEASLES VIRUS; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RUBELLA VIRUS; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS STRAIN;

GENOME, VIRAL; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VIRUS; RUBELLA VIRUS; SEQUENCE ANALYSIS, DNA; VACCINES, ATTENUATED;

EID: 61849164502     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.112     Document Type: Article

References (34)

1. Hilleman M.R. Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20 5-6 (2002) 651-665
2. Hviid A., Rubin S., and Muhlemann K. Mumps Lancet 371 9616 (2008) 932-944
3. Plotkin S.A. Rubella eradication. Vaccine 19 25-26 (2001) 3311-3319
4. Enders J.F., and Peebles T.C. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86 2 (1954) 277-286
5. Rota J.S., Wang Z.D., Rota P.A., and Bellini W.J. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 31 3 (1994) 317-330
6. Schwarz A.J. Preliminary tests of a highly attenuated measles vaccine. Am J Dis Child 103 (1962) 386-389
7. Hilleman M.R., Buynak E.B., Weibel R.E., Stokes Jr. J., Whitman Jr. J.E., and Leagus M.B. Development and evaluation of the Moraten measles virus vaccine. JAMA 206 3 (1968) 587-590
8. Parks C.L., Lerch R.A., Walpita P., Wang H.P., Sidhu M.S., and Udem S.A. Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage. J Virol 75 2 (2001) 921-933
9. Parks C.L., Lerch R.A., Walpita P., Wang H.P., Sidhu M.S., and Udem S.A. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 75 2 (2001) 910-920
10. World Health Organization. Measles vaccines. Wkly Epidemiol Rec 79 14 (2004) 130-142
11. Buynak E.B., and Hilleman M.R. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med 123 3 (1966) 768-775
12. Afzal M.A., Pickford A.R., Forsey T., and Minor P.D. Heterogeneous mumps vaccine. Lancet 340 8825 (1992) 980-981
13. Afzal M.A., Pickford A.R., Forsey T., Heath A.B., and Minor P.D. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol 74 Pt 5 (1993) 917-920
14. Amexis G., Rubin S., Chizhikov V., Pelloquin F., Carbone K., and Chumakov K. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 300 2 (2002) 171-179
15. Plotkin S.A., Farquhar J.D., Katz M., and Buser F. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. Am J Dis Child 118 2 (1969) 178-185
16. Wellington K., and Goa K.L. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Drugs 63 19 (2003) 2107-2126
17. Peltola H., Davidkin I., Paunio M., Valle M., Leinikki P., and Heinonen O.P. Mumps and rubella eliminated from Finland. JAMA 284 20 (2000) 2643-2647
18. Carter H., and Campbell H. Rational use of measles, mumps and rubella (MMR) vaccine. Drugs 45 5 (1993) 677-683
19. Schuster V., Otto W., Maurer L., Tcherepnine P., Pfletschinger U., Kindler K., et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 27 8 (2008) 724-730
20. Vesikari T., Sadzot-Delvaux C., Rentier B., and Gershon A. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J 26 7 (2007) 632-638
21. Kuter B.J., Brown M.L., Hartzel J., Williams W.R., EvesiKaren A., Black S., et al. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin 2 5 (2006) 205-214
22. Tillieux S.L., Halsey W.S., Thomas E.S., Voycik J.J., Sathe G.M., and Vassilev V. The complete DNA sequences of two Oka-strain Varicella-Zoster virus genomes. J Virol 82 22 (2008) 11023-11044
23. Nagai Y., and Kato A. Accessory genes of the paramyxoviridae, a large family of nonsegmented negative-strand RNA viruses, as a focus of active investigation by reverse genetics. Curr Top Microbiol Immunol 283 (2004) 197-248
24. Paterson R.G., and Lamb R.A. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol 64 9 (1990) 4137-4145
25. Bankamp B., Bellini W.J., and Rota P.A. Comparison of L proteins of vaccine and wild-type measles viruses. J Gen Virol 80 Pt 7 (1999) 1617-1625
26. Rota P.A., Bloom A.E., Vanchiere J.A., and Bellini W.J. Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology 198 2 (1994) 724-730
27. EPI. Expanded Programme on Immunization. Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 73 35 (1998) 265-269
28. Vesikari T., Andre F.E., Simoen E., Florent G., Ala-Laurila E.L., Heikkinen A., et al. Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children. Acta Paediatr Scand 72 1 (1983) 41-46
29. Walpita P. An internal element of the measles virus antigenome promoter modulates replication efficiency. Virus Res 100 2 (2004) 199-211
30. Bosma T.J., Best J.M., Corbett K.M., Banatvala J.E., and Starkey W.G. Nucleotide sequence analysis of a major antigenic domain of the E1 glycoprotein of 22 rubella virus isolates. J Gen Virol 77 Pt 10 (1996) 2523-2530
31. Frey T.K., and Abernathy E.S. Identification of strain-specific nucleotide sequences in the RA 27/3 rubella virus vaccine. J Infect Dis 168 4 (1993) 854-864
32. Nakhasi H.L., Thomas D., Zheng D.X., and Liu T.Y. Nucleotide sequence of capsid, E2 and E1 protein genes of Rubella virus vaccine strain RA27/3. Nucleic Acids Res 17 11 (1989) 4393-4394
33. Pugachev K.V., Abernathy E.S., and Frey T.K. Genomic sequence of the RA27/3 vaccine strain of rubella virus. Arch Virol 142 6 (1997) 1165-1180
34. Kulkarni-Kale U., Ojha J., Manjari G.S., Deobagkar D.D., Mallya A.D., Dhere R.M., et al. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 359 2 (2007) 436-446